PharmaVOICE - 
September 2007
Purchase Issue

In Every Issue
Last Word
Throughout his career, Joseph Bolen, Ph.D., has been involved in [...]
By
What’s New
Cardinal Health PTS is Renamed Catalent Cardinal Health Pharmaceutical Technologies [...]
By
Letter from the Editor
The pharmaceutical industry can no longer afford to be off-message [...]
By

Taren Grom, Editor

Talent Pool
Pharma POOL Dr. Frank Deane Dr. Dale M. Edgar Lilly [...]
By
E-Media
PharmaLinx Launches Industry Web Portal Professionals who operate in the [...]
By
On the Calendar
Industry Events September 2007 On the Calendar September 16-18 3rd [...]
By
PharmaOutlet
Contributed by Peter H. Nalen Beyond Hits and Clicks: A [...]
By

Peter H. Nalen

For Art’s Sake
Each month, this department pays homage to memorable advertising and [...]
By
UpFront
Online update SURF’s UP According to Manhattan Research’s latest study, [...]
By
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Lipitor Perceived as [...]
By

On The Cover

Success Beyond the Silos
By Robin Robinson Forum Innovative pharmaceutical companies are redefining the communications process by tearing down the walls between the different factions: agencies, sales, marketing, and public relations. More and more pharmaceutical companies are breaking out of their siloed structure to reach their audiences more efficiently and more cost-effectively. Squeezed on all sides by regulatory requirements, [...]
By

Robin Robinson

Features

A Born Leader — Ethan Leder
By Kim Ribbink Ethan Leder has made a career out of establishing companies in niche markets. Now he is applying the skills he’s learned to evidence-based solutions specialist United BioSource Corp. With an entrepreneurial spirit and intense work ethic, Ethan D. Leder has made a career out of establishing companies in niche markets. After enjoying [...]
By

Kim Ribbink

7 Rules for New War Games
Stan Bernard of Bernard Associates says practicing competitive simulations is a better approach than war games because simulations address more of the challenges that companies face. Traditionally, businesses have engaged in war games, in which marketing groups or brand teams compete by dividing into groups representing themselves and their competitors to test marketing elements and [...]
By
DIA 2007 — Annual Conference
DIA Addresses extreme topics The 43rd Annual Meeting of the Drug Information Association DIA 2007 — Annual Conference The Drug Information Association’s 43rd annual meeting featured 450 sessions and more than 1,000 speakers. Industry Thought Leaders Raise their VOICE at DIA Podcasts BBK Worldwide Thought Leader Bonnie Brescia, Cofounder Episode Trends in Patient Recruitment MediciGroup [...]
By
HIV Market: Stability in Motion
By Denise Myshko In response to several challenges, the focus of biotech and pharmaceutical development in HIV has shifted to novel classes. HIV is a retrovirus that is constantly adapting and evolving. Rates of drug-related resistance are on the rise and not all antiretroviral agents work for all people. In response to these challenges, the [...]
By

Denise Myshko

To Pharma TV or Not TV?
Pharmaceutical companies are discussing innovative initiatives to educate patients and consumers in Europe. By Robin Robinson A DVD created by the European Federation of Pharmaceutical Industries and Associations (EFPIA) ignited unfounded rumors that the industry was preparing to challenge the current ban on DTC advertising in Europe. Although untrue, the allegations sparked a robust discussion [...]
By

Robin Robinson

Postmarketing Safety in the Spotlight
Improving prescription drug safety and oversight have taken center stage both within Congress and with regulatory authorities. Postmarketing research is an important element of commercialization that enables companies to expand existing markets, enter new markets, develop and deliver messaging that directly compares their products with the competition, and secure a niche position in crowded markets. [...]
By

Denise Myshko

Managed Markets: Workers’ Comp Pharmacy Costs Rising
By Denise Myshko Total spend for drugs in the workers’ compensation arena is expected to be .5 billion in 2007 and represents 15% of total medical costs associated with workers’ compensation. This is the fastest growing component of the system’s medical expense. The use of generic drugs is significant in workers’ compensation, and pharmacy benefit [...]
By

Denise Myshko

FEEDBACK